JTE-907
Product Specifications
UNSPSC Description
JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo[1].
Target Antigen
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jte-907.html
Purity
98.72
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CC2=C(NC1=O)C(OCCCCC)=C(OC)C=C2)NCC3=CC=C(OCO4)C4=C3
Molecular Weight
438.47
References & Citations
[1]Ueda Y, et al. Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur J Pharmacol. 2005 Sep 27;520(1-3):164-71.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-103325/JTE-907-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-103325/JTE-907-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
282089-49-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1304522-01 0.02 mg (E-Coli)
Recombinant Pseudomonas fluorescens Argininosuccinate synthase (argG)
Ask
View Details MBS1304522-02 0.02 mg (Yeast)
Recombinant Pseudomonas fluorescens Argininosuccinate synthase (argG)
Ask
View Details MBS1304522-03 0.1 mg (E-Coli)
Recombinant Pseudomonas fluorescens Argininosuccinate synthase (argG)
Ask
View Details 
MBS1304522-04 0.1 mg (Yeast)
Recombinant Pseudomonas fluorescens Argininosuccinate synthase (argG)
Ask
View Details